Sign the Petition:
Search OCA:
Get Local!

Find Local News, Events & Green Businesses on OCA's State Pages:

OCA News Sections

Organic Consumers Association

CU Says FDA Assessment of GE Salmon Is Flawed and Inadequate

For related articles and more information, please visit OCA's Genetic Engineering page, Millions Against Monsanto page.

Yonkers, NY - Consumers Union, the advocacy and policy arm of Consumer Reports, criticized the Environmental Assessment (EA) of the Aquabounty genetically engineered salmon released today by the Food and Drug Administration (FDA), as flawed and inadequate.

"The EA states that the FDA has found that the salmon is safe to eat. However, we are deeply concerned that the potential of these fish to cause allergic reactions has not been adequately researched. FDA has allowed this fish to move forward based on tests of allergenicity of only six engineered fish-tests that actually did show an increase in allergy-causing potential," stated Michael Hansen PhD, Senior Scientist with Consumers Union. "Further, there have been no safety testing of fish grown in Panama, where Aquabounty intends to raise the salmon. The health and safety of fish can be affected by growing conditions."

"We are also concerned that FDA puts great weight, in their finding of 'no significant impact' on the fact that the engineered salmon would be sterile females. However FDA indicates that only 95 percent of the salmon may be sterile, and the rest fertile. When you are talking about millions of fish, even one percent comes to thousands of fish. Moreover, perhaps even more important, the fish at the egg production facility in Prince Edward Island, Canada would obviously not be sterile-otherwise they could not produce eggs," Hansen states.


>>> Read the Full Article

For more information on this topic or related issues you can search the thousands of archived articles on the OCA website using keywords: